{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:26:59Z","timestamp":1791617219980,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.chest.2015.11.017","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T04:16:00Z","timestamp":1454645760000},"page":"516-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%?"],"prefix":"10.1016","volume":"149","author":[{"given":"James M.","family":"Trauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nompilo","family":"Moyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ee-Laine","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Ragonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma S.","family":"McBryde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin T.","family":"Denholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.chest.2015.11.017_bib1","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.chest.2015.11.017_bib2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic","volume":"163","author":"Corbett","year":"2003","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.chest.2015.11.017_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1183\/09031936.00070812","article-title":"Contact investigation for tuberculosis: a systematic review and meta-analysis","volume":"41","author":"Fox","year":"2013","journal-title":"Eur\u00a0Respir J"},{"issue":"4 pt 2","key":"10.1016\/j.chest.2015.11.017_bib4","first-page":"S221","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2015.11.017_bib5","doi-asserted-by":"crossref","first-page":"866","DOI":"10.5588\/ijtld.12.0573","article-title":"Data needs for evidence-based decisions: a tuberculosis modeler's \u2018wish list.'","volume":"17","author":"Dowdy","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.chest.2015.11.017_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/380966","article-title":"Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial","volume":"38","author":"Jasmer","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.chest.2015.11.017_bib7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.7326\/0003-4819-127-12-199712150-00001","article-title":"Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis","volume":"127","author":"Salpeter","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.chest.2015.11.017_bib8","unstructured":"Centers for Disease Control and Prevention. Tuberculosis (TB) fact sheets: the difference between latent TB infection and TB diseases. http:\/\/www.cdc.gov\/tb\/publications\/factsheets\/general\/ltbiandactivetb.htm. Accessed May 29,\u00a02015."},{"key":"10.1016\/j.chest.2015.11.017_bib9","unstructured":"World Health Organization. Latent tuberculosis infection (LTBI). http:\/\/www.who.int\/tb\/challenges\/ltbi\/en\/. Accessed May 29,\u00a02015."},{"issue":"7624","key":"10.1016\/j.chest.2015.11.017_bib10","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.chest.2015.11.017_bib11","first-page":"CD001363","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons","author":"Smieja","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.chest.2015.11.017_bib12","first-page":"827","article-title":"Isoniazid prophylaxis among Alaskan Eskimos: a final report of the Bethel isoniazid studies","volume":"119","author":"Comstock","year":"1979","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.chest.2015.11.017_bib13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.5588\/pha.15.0018","article-title":"Evaluation of tuberculin skin testing in tuberculosis contacts in Victoria, Australia 2005-2013","volume":"5","author":"Moyo","year":"2015","journal-title":"Public Health Action"},{"key":"10.1016\/j.chest.2015.11.017_bib14","unstructured":"Centers for Disease Control and Prevention. TB elimination, tuberculin skin testing. http:\/\/www.cdc.gov\/tb\/publications\/factsheets\/testing\/skintesting.pdf. Accessed July 2,\u00a02015."},{"issue":"8","key":"10.1016\/j.chest.2015.11.017_bib15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jama.287.8.991","article-title":"Evaluation of investigations conducted to detect and prevent transmission of tuberculosis","volume":"287","author":"Reichler","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.chest.2015.11.017_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","article-title":"Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion","volume":"159","author":"Menzies","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2015.11.017_bib17","unstructured":"The World Bank. Incidence of tuberculosis (per 100,000 people). http:\/\/data.worldbank.org\/indicator\/SH.TBS.INCD\/countries. Accessed May 15,\u00a02015."},{"key":"10.1016\/j.chest.2015.11.017_bib18","unstructured":"Australian Government, Department of Health. Tuberculosis case definition. http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-surveil-nndss-casedefs-cd_tb.htm. Accessed July 2,\u00a02015."},{"issue":"4","key":"10.1016\/j.chest.2015.11.017_bib19","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis","volume":"60","year":"1982","journal-title":"Bull World Health Organization"},{"issue":"10","key":"10.1016\/j.chest.2015.11.017_bib20","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?","volume":"3","author":"Comstock","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.chest.2015.11.017_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/DHPS.S68837","article-title":"Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study","volume":"6","author":"Denholm","year":"2014","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.chest.2015.11.017_bib22","unstructured":"Australian Bureau of Statistics. 3101.0 Australian demographic statistics. Interstate departures, states and territories (persons). http:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/DetailsPage\/3101.0Sep%202014?OpenDocument. Accessed May 28,\u00a02015."},{"key":"10.1016\/j.chest.2015.11.017_bib23","unstructured":"Australian Bureau of Statistics. 3302.0, Deaths, Australia, 2013. Death rates, states and territories, 2003 to 2013. http:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/DetailsPage\/3302.02013?OpenDocument. Accessed May 28,\u00a02015."},{"issue":"1","key":"10.1016\/j.chest.2015.11.017_bib24","first-page":"38","article-title":"A\u00a0prospective evaluation of children under the age of 5 years living in the same household as adults with recently diagnosed pulmonary tuberculosis","volume":"1","author":"Beyers","year":"1997","journal-title":"Int J Tuberc Lung Dis"},{"issue":"20","key":"10.1016\/j.chest.2015.11.017_bib25","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States","volume":"350","author":"Horsburgh","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2015.11.017_bib26","first-page":"310","article-title":"Tuberculin skin test: estimation of positive and negative predictive values from routine data","volume":"9","author":"Berkel","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"10.1016\/j.chest.2015.11.017_bib27","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"10.1016\/j.chest.2015.11.017_bib28","first-page":"1112","article-title":"Risk\u00a0factors for developing tuberculosis: a\u00a012-year follow-up of contacts of tuberculosis cases","volume":"14","author":"Moran-Mendoza","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"10.1016\/j.chest.2015.11.017_bib29","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/rccm.201406-1159OC","article-title":"Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam","volume":"190","author":"Sloot","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2015.11.017_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201006-0974OC","article-title":"Negative and positive predictive value of a whole-blood interferon-gamma release assay for developing active tuberculosis: an update","volume":"183","author":"Diel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2015.11.017_bib31","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1183\/09031936.00098509","article-title":"Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts","volume":"35","author":"Kik","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2015.11.017_bib32","first-page":"28","article-title":"Controlled chemoprophylaxis trials in tuberculosis. A general review","volume":"26","author":"Ferebee","year":"1970","journal-title":"Bibl Tuberc"},{"issue":"2","key":"10.1016\/j.chest.2015.11.017_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a121593","article-title":"The prognosis of a positive tuberculin reaction in childhood and adolescence","volume":"99","author":"Comstock","year":"1974","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.chest.2015.11.017_bib34","first-page":"517","article-title":"A\u00a0controlled study of the influence of segregation of tuberculous patients for one year on the attack rate of tuberculosis in a 5-year period in close family contacts in South India","volume":"34","author":"Kamat","year":"1966","journal-title":"Bull World Health Organization"},{"issue":"2","key":"10.1016\/j.chest.2015.11.017_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0950268897007917","article-title":"The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection","volume":"119","author":"Vynnycky","year":"1997","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.1016\/j.chest.2015.11.017_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/aje\/152.3.247","article-title":"Lifetime risks, incubation period, and serial interval of tuberculosis","volume":"152","author":"Vynnycky","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.chest.2015.11.017_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0041-3879(82)80013-5","volume":"63","author":"Sutherland","year":"1982","journal-title":"Tubercle"},{"key":"10.1016\/j.chest.2015.11.017_bib38","article-title":"National Tuberculosis Advisory Committee for the Communicable Diseases Network of Australia. Tuberculosis notifications in Australia, 2012 and 2013","author":"Toms","year":"2015","journal-title":"Communicable Diseases Intelligence Quarterly Report"},{"issue":"3","key":"10.1016\/j.chest.2015.11.017_bib39","first-page":"419","article-title":"The use of isoniazid among household contacts of open cases of pulmonary tuberculosis","volume":"33","author":"Egsmose","year":"1965","journal-title":"Bull\u00a0World Health Organiz"},{"issue":"23","key":"10.1016\/j.chest.2015.11.017_bib40","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.chest.2015.11.017_bib41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/IDR.S8994","article-title":"The use of anti-tuberculosis therapy for latent TB infection","volume":"3","author":"Denholm","year":"2010","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.chest.2015.11.017_bib42","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJM196110122651501","article-title":"Preventive effects of isoniazid in the treatment of primary tuberculosis in children","volume":"265","author":"Mount","year":"1961","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.chest.2015.11.017_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2334-14-91","article-title":"Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis","volume":"14","author":"Ayieko","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.chest.2015.11.017_bib44","series-title":"HIV, Viral Hepatitis and Sexually Transmissible Infections in Australia Annual Surveillance Report 2013","year":"2013"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215002494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215002494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T14:26:50Z","timestamp":1537021610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215002494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0012369215002494"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2015.11.017","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%?","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2015.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}